FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and …
Federal Trade Commission sues largest drug middlemen for ... - CNN
Sep 20, 2024 · The agency alleges that CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx and their affiliated group purchasing organizations created a …
Express Scripts® Further Advances Transparency and …
Apr 13, 2023 · Express Scripts is introducing a new and innovative solution, the Copay Assurance plan, which caps consumer out-of-pocket costs for prescription drugs under a client's …
Express Scripts sues FTC over drug pricing report | Reuters
Sep 17, 2024 · Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling the report's …
Express Scripts conspired to overcharge pharmacies, class ...
Oct 20 (Reuters) - A group of pharmacies has filed a proposed class action lawsuit accusing Cigna Group's (CI.N) pharmacy benefit manager unit Express Scripts Inc of conspiring with …
Drug middlemen illegally drive up the cost of insulin, FTC says
Sep 20, 2024 · The companies — CVS-owned Caremark Rx, Cigna Group's Express Scripts and UnitedHealth Group's Optum Rx — acted in ways that stifled industry competition for insulin …
Federal regulators sue St. Louis-based Express Scripts | STLPR
Sep 30, 2024 · The Federal Trade Commission on Sept. 20 filed a complaint against pharmacy benefit manager Express Scripts, alleging it and two other companies, OptumRx and …
Federal Trade Commission accuses three drug middlemen of …
Sep 21, 2024 · The FTC accused the "Big Three" pharmacy benefit managers (PBMs) — UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts — of …
Express Scripts Sues FTC Over Drug Pricing Report - U.S. News
Sep 17, 2024 · NEW YORK (Reuters) -Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling …
Express Scripts Adds Three Biosimilars to Largest Formulary to …
Jul 10, 2023 · The biosimilar Amjevita (Amgen), citrate-free, low concentration formulation, is currently preferred on the Express Scripts NPF and the National Preferred Flex Formulary for …
- Some results have been removed